Azitra

Azitra EBITDA per Share

The EBITDA per Share of Azitra (AZTR) as of Oct 22, 2026 is -1.02 USD. In the previous year, EBITDA per Share was -9.59 USD — a change of -89.36% (higher).

EBITDA per Share

-1.02USD

YoY

-89.36%

Last updated:

EBITDA per Share of Azitra is 2025 -1.02 USD. EBITDA per Share of Azitra was 2024 -9.59 USD. It decreases by -89.36% higher compared to the previous year.

The Azitra EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2021
-0.48 USD
Jan 1, 2022
-156.26 USD
Jan 1, 2023
-123.15 USD
Jan 1, 2024
-9.59 USD
Jan 1, 2025
-1.02 USD
The Azitra EBITDA per Share history
YEAREBITDA per ShareYoY
-1.02USD-89.36%
-9.59USD-92.21%
-123.15USD-21.19%
-156.26USD+32,605.12%
-0.48USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Azitra Stock analysis

What does Azitra do? Azitra Inc., based in Branford, Connecticut, is an early-stage biopharmaceutical company focused on developing topical therapies for dermatological conditions. The company utilizes engineered proteins and live biotherapeutic products, leveraging a microbial library of 1,500 bacterial strains and AI-driven screening to create treatments for skin diseases. Its pipeline includes ATR-12 for Netherton syndrome, ATR-04 for papulopustular rash, and ATR-01 for ichthyosis vulgaris, all targeting unmet medical needs in precision dermatology. Listed on June 16, 2023, Azitra operates with a team of 10 employees. Azitra is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Azitra stock

EBITDA per Share of Azitra is -1.02 USD in 2025.

EBITDA per Share of Azitra changed from -9.59 USD to -1.02 USD, representing a -89.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Azitra since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Azitra

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Azitra